Cambridge Investment Research Advisors’s Social Capital Hedosophia Holdings Corp. VI Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 IPOF.WS Stock Holding History
Bought
Maintained
Sold
Cambridge Investment Research Advisors's IPOF.WS Position: Q3 2022 in Review
Cambridge Investment Research Advisors sold out of Social Capital Hedosophia Holdings Corp. VI Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (IPOF.WS) in Q3 2022, closing a stake of 2,334,124 shares — an estimated $1.12M sold.
Cambridge Investment Research Advisors first reported a position in IPOF.WS in Q1 2021 and held it in 6 quarters. The position peaked at $1.87M in Q1 2022. 6 funds tracked by Wall St. Rank hold IPOF.WS as of Q3 2022.
- Cambridge Investment Research Advisors reported no remaining Social Capital Hedosophia Holdings Corp. VI Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
- Cambridge Investment Research Advisors sold 2,334,124 Social Capital Hedosophia Holdings Corp. VI Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2022, an estimated $1.12M.
- Cambridge Investment Research Advisors first reported a position in Social Capital Hedosophia Holdings Corp. VI Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2021 and held it in 6 quarters.
- Cambridge Investment Research Advisors's Social Capital Hedosophia Holdings Corp. VI Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $1.87M in Q1 2022.
- 6 funds tracked by Wall St. Rank held Social Capital Hedosophia Holdings Corp. VI Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2022.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.